It's been a rocky few months for Novo Nordisk.Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival Zepbound from Eli Lilly. Wegovy's potential successor, CagriSema, came up short of investor expectations in a closely watched Phase 3 trial. Novo's stock has fallen more than...
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.None of the roughly 2,000 women in the trial who received Gilead's shot lenacapavir had...
Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test.Md Babul Hosen | Istock | Getty ImagesThe U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in patients with sickle cell disease.The approval comes about...
At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a dozen. All the result of sickle cell disease, an inherited blood disorder where a genetic mutation causes normally full-moon shaped red...
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty ImagesNovo Nordisk's Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart...
A worker organizes cans of PepsiCo Inc. soda on a shelf inside a grocery store in Phoenix, Arizona, U.S., on Thursday, July 6, 2017. PepsiCo Inc. is scheduled to release earnings figures on July 11. Photographer: Caitlin O'Hara/Bloomberg via Getty ImagesBloomberg | Bloomberg | Getty ImagesIf you listen to...
A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice.Swen Pförtner | Picture Alliance | Getty ImagesTwo new immunizations promise to protect babies from respiratory syncytial virus – if people can find them. Providers are scrambling to offer Pfizer's vaccine, Abrysvo,...